# Sitagliptin and Endothelial Dysfunction

> **NCT02406950** · PHASE3 · UNKNOWN · sponsor: **Kyunghee University Medical Center** · enrollment: 10 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Sitagliptin

## Key facts

- **NCT ID:** NCT02406950
- **Lead sponsor:** Kyunghee University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-02
- **Primary completion:** 2015-06
- **Final completion:** 2015-08
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2015-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02406950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02406950, "Sitagliptin and Endothelial Dysfunction". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02406950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*